[Outcomes of 27G(+) transconjunctival sutureless vitrectomy for posterior segment disease].

To report the clinical outcomes and safety profile of 27G(+) transconjunctival sutureless vitrectomy (TSV) in eyes with posterior segment disease. Prospective, interventional case series. Eyes undergoing 27G(+) TSV for a vitreoretinal surgery indication were included from Dec 2015 to Mar 2016. Change in visual acuity and occurrence of intraoperative and postoperative complications with minimum follow-up of 6 weeks were recorded. Eighty-three eyes met the inclusion criteria. Surgical indications included epiretinal membrane (27), proliferative diabetic retinopathy (17), full-thickness macular hole (11), rhegmatogenous retinal detachment with or without proliferative vitreoretinopathy (PVR) (8), vitreous hemorrhage(7), vitreous opacities (7), diabetic macular edema non-response to anti-VEGF agents(4), intraocular lens or cataract nucleus dropped into vitreous cavity (2). Mean follow-up was 19 weeks (range 6-34 weeks). Visual acuity improved in all cases. The cutter incarcerated with trocar in a vitreous hemorrhage case. There were no other intraoperative complications and no case required sutured at the conclusion of surgery. Postoperative complications included transient ocular hypertension in 2 eyes (2.4%) and transient hypotony in 1 eye (1.2%). No cases of postoperative endophthalmitis, sclerotomy related retinal tears, or choroidal detachments were encountered in the follow-up period. The 27G(+) TSV was effective and safe for varied surgical indications with low rates of intraoperative and postoperative complications. .